Alterations in junctional proteins, inflammatory mediators and extracellular matrix molecules in eosinophilic esophagitis

Clinical Immunology

Volumn 148, Issue 2, 2013, Pages 265-278

  Abdulnour Nakhoul, Solange M ^a   Al Tawil, Youhanna ^b   Gyftopoulos, Alex A ^a   Brown, Karen L ^a   Hansen, Molly ^b   Butcher, Kathy F ^b   Eidelwein, Alexandra P ^b   Noel, Robert A ^b   Rabon, Edd ^a   Posta, Allison ^a   Nakhoul, Nazih L ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b East Tennessee Children's Hospital   (United States)

Author keywords

Claudin 1; Cytokines; E cadherin; Inflammation; Occludin; Vimentin

Indexed keywords

ADAMTS1 PROTEIN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR3; CLAUDIN 1; CXCL1 CHEMOKINE; CYTOKINE ANTIBODY; EOTAXIN 2; EOTAXIN 3; EPIDERMAL GROWTH FACTOR; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ALPHA; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; MATRIX METALLOPROTEINASE 14; NEUROTROPHIN 3; OCCLUDIN; STEM CELL FACTOR; TIGHT JUNCTION PROTEIN; UVOMORULIN; VIMENTIN;

ADOLESCENT; ARTICLE; CELL JUNCTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; ESOPHAGUS BIOPSY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; SCHOOL CHILD; TIGHT JUNCTION; TISSUE INJURY; UPREGULATION; WESTERN BLOTTING;

CLAUDIN-1; CYTOKINES; E-CADHERIN; INFLAMMATION; OCCLUDIN; VIMENTIN;

ADHERENS JUNCTIONS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; JUNCTIONAL ADHESION MOLECULES; MALE; TIGHT JUNCTION PROTEINS; VIMENTIN;

EID: 84880263547     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.05.004     Document Type: Article

References (51)

1. Liacouras C.A., Furuta G.T., Hirano I., Atkins D., Attwood S.E., Bonis P.A., Burks A.W., Chehade M., Collins M.H., Dellon E.S., Dohil R., Falk G.W., Gonsalves N., Gupta S.K., Katzka D.A., Lucendo A.J., Markowitz J.E., Noel R.J., Odze R.D., Putnam P.E., Richter J.E., Romero Y., Ruchelli E., Sampson H.A., Schoepfer A., Shaheen N.J., Sicherer S.H., Spechler S., Spergel J.M., Straumann A., Wershil B.K., Rothenberg M.E., Aceves S.S. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J. Allergy Clin. Immunol. 2011, 128:3-20. (e26; quiz 21-22).
2. Kelly K.J., Lazenby A.J., Rowe P.C., Yardley J.H., Perman J.A., Sampson H.A. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995, 109:1503-1512.
3. Furuta G.T. Eosinophilic esophagitis: update on clinicopathological manifestations and pathophysiology. Curr. Opin. Gastroenterol. 2011, 27:383-388.
4. Mishra A., Rothenberg M.E. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003, 125:1419-1427.
5. Hogan S.P., Mishra A., Brandt E.B., Royalty M.P., Pope S.M., Zimmermann N., Foster P.S., Rothenberg M.E. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat. Immunol. 2001, 2:353-360.
6. Aceves S.S., Newbury R.O., Dohil R., Bastian J.F., Broide D.H. Esophageal remodeling in pediatric eosinophilic esophagitis. J. Allergy Clin. Immunol. 2007, 119:206-212.
7. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:2002-2007.
8. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
9. Cheng E., Zhang X., Huo X., Yu C., Zhang Q., Wang D.H., Spechler S.J., Souza R.F. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2012.
10. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991, 251:1451-1455.
11. Jovov B., Que J., Tobey N.A., Djukic Z., Hogan B.L., Orlando R.C. Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am. J. Gastroenterol. 2011, 106:1039-1047.
12. Martinez C., Lobo B., Pigrau M., Ramos L., Gonzalez-Castro A.M., Alonso C., Guilarte M., Guila M., de Torres I., Azpiroz F., Santos J., Vicario M. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut 2012, 10.1136/gutjnl-2012-302093.
13. Mazzon E., Sturniolo G.C., Puzzolo D., Frisina N., Fries W. Effect of stress on the paracellular barrier in the rat ileum. Gut 2002, 51:507-513.
14. Terris B., Potet F. Structure and role of Langerhans' cells in the human oesophageal epithelium. Digestion 1995, 56(Suppl. 1):9-14.
15. Mishra A., Hogan S.P., Brandt E.B., Rothenberg M.E. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J. Clin. Invest. 2001, 107:83-90.
16. Blanchard C., Wang N., Stringer K.F., Mishra A., Fulkerson P.C., Abonia J.P., Jameson S.C., Kirby C., Konikoff M.R., Collins M.H., Cohen M.B., Akers R., Hogan S.P., Assa'ad A.H., Putnam P.E., Aronow B.J., Rothenberg M.E. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 2006, 116:536-547.
17. Mishra A., Hogan S.P., Brandt E.B., Rothenberg M.E. IL-5 promotes eosinophil trafficking to the esophagus. J. Immunol. 2002, 168:2464-2469.
18. Eum S.Y., Haile S., Lefort J., Huerre M., Vargaftig B.B. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:12290-12294.
19. Blanchard C., Stucke E.M., Rodriguez-Jimenez B., Burwinkel K., Collins M.H., Ahrens A., Alexander E.S., Butz B.K., Jameson S.C., Kaul A., Franciosi J.P., Kushner J.P., Putnam P.E., Abonia J.P., Rothenberg M.E. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J. Allergy Clin. Immunol. 2010, 127:208-217. (217 e201-207).
20. Van Damme J., Wuyts A., Froyen G., Van Coillie E., Struyf S., Billiau A., Proost P., Wang J.M., Opdenakker G. Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage. J. Leukoc. Biol. 1997, 62:563-569.
21. Blanchard C., Stucke E.M., Rodriguez-Jimenez B., Burwinkel K., Collins M.H., Ahrens A., Alexander E.S., Butz B.K., Jameson S.C., Kaul A., Franciosi J.P., Kushner J.P., Putnam P.E., Abonia J.P., Rothenberg M.E. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J. Allergy Clin. Immunol. 2011, 127:208-217. (217 e201-207).
22. Hamaguchi M., Fujiwara Y., Takashima T., Hayakawa T., Sasaki E., Shiba M., Watanabe T., Tominaga K., Oshitani N., Matsumoto T., Higuchi K., Arakawa T. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion 2003, 68:189.
23. Prause O., Laan M., Lotvall J., Linden A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur. J. Pharmacol. 2003, 462:193-198.
24. Towne J.E., Garka K.E., Renshaw B.R., Virca G.D., Sims J.E. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J. Biol. Chem. 2004, 279:13677-13688.
25. Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002, 13:323-340.
26. Pure E., Assoian R.K. Rheostatic signaling by CD44 and hyaluronan. Cell. Signal. 2009, 21:651-655.
27. Katoh S., Matsumoto N., Kawakita K., Tominaga A., Kincade P.W., Matsukura S. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J. Clin. Invest. 2003, 111:1563-1570.
28. Itoh Y., Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell. Physiol. 2006, 206:1.
29. Gingras D., Bã©liveau R. Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity. Biochim. Biophys. Acta 2010, 1803:142.
30. Paulissen G., Rocks N., Gueders M.M., Crahay C., Quesada-Calvo F., Bekaert S., Hacha J., El Hour M., Foidart J.M., Noel A., Cataldo D.D. Role of ADAM and ADAMTS metalloproteinases in airway diseases. Respir. Res. 2009, 10:127.
31. DiPietro L.A., Nissen N.N., Gamelli R.L., Koch A.E., Pyle J.M., Polverini P.J. Thrombospondin 1 synthesis and function in wound repair. Am. J. Pathol. 1996, 148:1851-1860.
32. Evans R.D., Itoh Y. Analyses of MT1-MMP activity in cells. Methods Mol. Med. 2007, 135:239-249.
33. Young B.B., Zhang G., Koch M., Birk D.E. The roles of types XII and XIV collagen in fibrillogenesis and matrix assembly in the developing cornea. J. Cell. Biochem. 2002, 87:208.
34. Howell S.J., Doane K.J. Type VI collagen increases cell survival and prevents anti-beta 1 integrin-mediated apoptosis. Exp. Cell Res. 1998, 241:230-241.
35. Steed E., Balda M.S., Matter K. Dynamics and functions of tight junctions. Trends Cell Biol. 2010, 20:142-149.
36. Capaldo C.T., Nusrat A. Cytokine regulation of tight junctions. Biochim. Biophys. Acta 2009, 1788:864-871.
37. Ahdieh M., Vandenbos T., Youakim A. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma. Am. J. Physiol. Cell Physiol. 2001, 281:C2029-C2038.
38. Marchiando A.M., Shen L., Graham W.V., Weber C.R., Schwarz B.T., Austin J.R., Raleigh D.R., Guan Y., Watson A.J., Montrose M.H., Turner J.R. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J. Cell Biol. 2010, 189:111-126.
39. Huber D., Balda M.S., Matter K. Occludin modulates transepithelial migration of neutrophils. J. Biol. Chem. 2000, 275:5773-5778.
40. Alexander J.S., Dayton T., Davis C., Hill S., Jackson T.H., Blaschuk O., Symonds M., Okayama N., Kevil C.G., Laroux F.S., Berney S.M., Kimpel D. Activated T-lymphocytes express occludin, a component of tight junctions. Inflammation 1998, 22:573-582.
41. Edelblum K.L., Shen L., Weber C.R., Marchiando A.M., Clay B.S., Wang Y., Prinz I., Malissen B., Sperling A.I., Turner J.R. Dynamic migration of γδ intraepithelial lymphocytes requires occludin. Proc. Natl. Acad. Sci. 2012, 109:7097-7102.
42. Weber C.R., Raleigh D.R., Su L., Shen L., Sullivan E.A., Wang Y., Turner J.R. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J. Biol. Chem. 2010, 285:12037-12046.
43. Van Itallie C.M., Fanning A.S., Holmes J., Anderson J.M. Occludin is required for cytokine-induced regulation of tight junction barriers. J. Cell Sci. 2010, 123:2844-2852.
44. Yassin T.M., Toner P.G. Langerhans cells in the human oesophagus. J. Anat. 1976, 122:435-445.
45. Mor-Vaknin N., Punturieri A., Sitwala K., Markovitz D.M. Vimentin is secreted by activated macrophages. Nat. Cell Biol. 2003, 5:59-63.
46. Kagalwalla A.F., Akhtar N., Woodruff S.A., Rea B.A., Masterson J.C., Mukkada V., Parashette K.R., Du J., Fillon S., Protheroe C.A., Lee J.J., Amsden K., Melin-Aldana H., Capocelli K.E., Furuta G.T., Ackerman S.J. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J. Allergy Clin. Immunol. 2012, 129:1387-1396. (e1387).
47. Johnson J.R., Roos A., Berg T., Nord M., Fuxe J. Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways. PLoS One 2011, 6:e16175.
48. Aceves S.S., Chen D., Newbury R.O., Dohil R., Bastian J.F., Broide D.H. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J. Allergy Clin. Immunol. 2010, 126:1198-1204.e1194.
49. Honke K., Wada Y. Regulation of vimentin expression and protease-mediated vimentin degradation during differentiation of human monocytic leukemia cells. Jpn. J. Cancer Res. 1997, 88:484-491.
50. Tilleman K., Van Steendam K., Cantaert T., De Keyser F., Elewaut D., Deforce D. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology (Oxford) 2008, 47:597-604.
51. Toda M., Kuo C.H., Borman S.K., Richardson R.M., Inoko A., Inagaki M., Collins A., Schneider K., Ono S.J. Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcepsilonRI/CC chemokine receptor 1 cross-talk. J. Biol. Chem. 2012, 287:24516-24524.